IDFC loan to Kodak for pharma ingredients hits a snag

SEC to probe Kodak insider trading on 28 July 2020

Screenshot via Internet of the Kodak stock price on the NYSE for the past month
Screenshot via Internet of the Kodak stock price on the NYSE for the past month

The US$ 765 loan IDFC loan to Kodak for producing pharma ingredients seems to have hit a snag with allegations being raised by the US senator from Massachusetts Elizabeth Warren. In an open letter to SEC Chairman Jay Clayton, senator Warren urged the agency to investigate “potential incidents of insider trading prior to the 28 July 2020, public announcement of the Trump administration’s US$ 765 million loan to Eastman Kodak Co. (Kodak) to support the production of generic drug ingredients in response to the coronavirus disease 2019 (COVID-19) pandemic.”

The International Development Finance Corporation, which was to give the loan tweeted late on Friday 7 August 2020, “On July 28, we signed a Letter of Interest with Eastman Kodak. Recent allegations of wrongdoing raise serious concerns. We will not proceed any further unless these allegations are cleared.”

It is said that Kodak’s stock moved 25% the day before the news was officially disclosed. It is alleged that some stock options were awarded just a day before the loan became public. According to media reports, Kodak shared information on the loan with an agreed-on embargo news embargo with a few media outlets before the public announcement. It is reported that some of the media published the information in violation of the embargo before they were asked to delete it.

Meanwhile, Kodak says it has launched its own investigation by a select committee. The company said, “The committee, comprised of directors Jason New and William G. Parrett, will oversee an internal review of recent activity by the company and related parties in connection with the announcement of a potential loan by the US International Development Finance Corporation to support the launch of Kodak Pharmaceuticals.”

In 2024, we are looking at full recovery and growth-led investment in Indian printing

Indian Printer and Publisher founded in 1979 is the oldest B2B trade publication in the multi-platform and multi-channel IPPGroup. It created the category of privately owned B2B print magazines in the country. And by its diversification in packaging, (Packaging South Asia), food processing and packaging (IndiFoodBev) and health and medical supply chain and packaging (HealthTekPak), and its community activities in training, research, and conferences (Ipp Services, Training and Research) the organization continues to create platforms that demonstrate the need for quality information, data, technology insights and events.

India is a large and tough terrain and while its book publishing and commercial printing industry have recovered and are increasingly embracing digital print, the Indian newspaper industry continues to recover its credibility and circulation. The signage industry is also recovering and new technologies and audiences such as digital 3D additive printing, digital textiles, and industrial printing are coming onto our pages. Diversification is a fact of life for our readers and like them, we will also have to adapt with agility to keep up with their business and technical information needs.

India is one of the fastest growing economies in nominal and real terms – in a region poised for the highest change in year to year expenditure in printing equipment and consumables. Our 2024 media kit is ready, and it is the right time to take stock – to emphasize your visibility and relevance to your customers and turn potential markets into conversations.

– Naresh Khanna

Subscribe Now


Please enter your comment!
Please enter your name here